Gary D. Kruh

9.0k total citations
70 papers, 6.9k citations indexed

About

Gary D. Kruh is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Gary D. Kruh has authored 70 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 27 papers in Molecular Biology and 20 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Gary D. Kruh's work include Drug Transport and Resistance Mechanisms (42 papers), Pharmacological Effects and Toxicity Studies (20 papers) and HIV/AIDS drug development and treatment (11 papers). Gary D. Kruh is often cited by papers focused on Drug Transport and Resistance Mechanisms (42 papers), Pharmacological Effects and Toxicity Studies (20 papers) and HIV/AIDS drug development and treatment (11 papers). Gary D. Kruh collaborates with scholars based in United States, Japan and China. Gary D. Kruh's co-authors include Martin G. Belinsky, Zhe‐Sheng Chen, Kun Hee Lee, Hao Zeng, Elizabeth Hopper-Borge, Irina Shchaveleva, Yanping Guo, Philip A. Rea, Elena Kotova and Erica A. Golemis and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Gary D. Kruh

70 papers receiving 6.8k citations

Peers

Countries citing papers authored by Gary D. Kruh

Since Specialization

Citations

This map shows the geographic impact of Gary D. Kruh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary D. Kruh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary D. Kruh more than expected).

Fields of papers citing papers by Gary D. Kruh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary D. Kruh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary D. Kruh. The network helps show where Gary D. Kruh may publish in the future.

Co-authorship network of co-authors of Gary D. Kruh

This figure shows the co-authorship network connecting the top 25 collaborators of Gary D. Kruh. A scholar is included among the top collaborators of Gary D. Kruh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary D. Kruh. Gary D. Kruh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Contribution of Abcc10 (Mrp7) to In Vivo Paclitaxel Resistance as Assessed in Abcc10−/− Mice 2011 ·Cancer Research ·Elizabeth Hopper-Borge, Timothy W. Churchill, (unknown), Émmanuelle Nicolas, Joely D. Jacobs, (unknown), Yehong Kuang, Alex Grinberg, Heiner Westphal, Zhe‐Sheng Chen, Andres J. Klein–Szanto, Martin G. Belinsky, Gary D. Kruh	59
2	Dose-Dependent Disposition of Methotrexate in Abcc2 and Abcc3 Gene Knockout Murine Models 2011 ·Drug Metabolism and Disposition ·Zhan Wang, Qingyu Zhou, Gary D. Kruh, James M. Gallo	13
3	The Taccalonolides: Microtubule Stabilizers That Circumvent Clinically Relevant Taxane Resistance Mechanisms 2008 ·Cancer Research ·April L. Risinger, Evelyn M. Jackson, Lisa Polin, Gregory L. Helms, (unknown), (unknown), Elizabeth Hopper-Borge, Richard F. Ludueña, Gary D. Kruh, Susan L. Mooberry	111
4	The organic solute transporter α-β, Ostα-Ostβ, is essential for intestinal bile acid transport and homeostasis 2008 ·Proceedings of the National Academy of Sciences ·Anuradha Rao, Jamie Haywood, Ann L. Craddock, Martin G. Belinsky, Gary D. Kruh, Paul A. Dawson	179
5	ABCC11 expression is regulated by estrogen in MCF7 cells, correlated with estrogen receptor expression in postmenopausal breast tumors and overexpressed in tamoxifen-resistant breast cancer cells 2008 ·Endocrine Related Cancer ·(unknown), (unknown), J.-P. Vendrell, Jérôme Guitton, Ivan Bièche, (unknown), Gary D. Kruh, Charles Dumontet, Pascale A. Cohen, Léa Payen	31
6	ABCC10, ABCC11, and ABCC12 2006 ·Pflügers Archiv - European Journal of Physiology ·Gary D. Kruh, Yanping Guo, Elizabeth Hopper-Borge, Martin G. Belinsky, Zhe‐Sheng Chen	111
7	Analysis of the contribution of MRP3 to in vivo chemosensitivity using knock out mice. 2004 ·Cancer Research ·Martin G. Belinsky, Irina Shchaveleva, Zhe‐Sheng Chen, Alan C. Sartorelli, Gary D. Kruh	1
8	Transport of Bile Acids, Sulfated Steroids, Estradiol 17-β-d-Glucuronide, and Leukotriene C4 by Human Multidrug Resistance Protein 8 (ABCC11) 2004 ·Molecular Pharmacology ·Zhe‐Sheng Chen, Yanping Guo, Martin G. Belinsky, Elena Kotova, Gary D. Kruh	107
9	Predicting drug sensitivity and resistance 2004 ·Cancer Cell ·Gergely Szakács, (unknown), Samir Lababidi, Uma Shankavaram, Angela Arciello, Kimberly J. Bussey, William C. Reinhold, Yanping Guo, Gary D. Kruh, Mark Reimers, John N. Weinstein, Michael M. Gottesman	436
10	The MRP family of drug efflux pumps 2003 ·Oncogene ·Gary D. Kruh, Martin G. Belinsky	484
11	Characterization of the Transport Properties of Human Multidrug Resistance Protein 7 (MRP7, ABCC10) 2003 ·Molecular Pharmacology ·Zhe‐Sheng Chen, Elizabeth Hopper-Borge, Martin G. Belinsky, Irina Shchaveleva, Elena Kotova, Gary D. Kruh	142
12	Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). 2002 ·PubMed ·Martin G. Belinsky, Zhe‐Sheng Chen, Irina Shchaveleva, Hao Zeng, Gary D. Kruh	201
13	多剤耐性蛋白質(MRP)3とMRP1によるメトトレキセート(MTX)と葉酸塩の輸送ポリグルタミル化がMTX輸送に及ぼす効果 2001 ·Cancer Research ·(unknown), (unknown), Martin G. Belinsky, (unknown), Gary D. Kruh	1
14	MRP Subfamily Transporters and Resistance to Anticancer Agents 2001 ·Journal of Bioenergetics and Biomembranes ·Gary D. Kruh, Hao Zeng, Philip A. Rea, Guosheng Liu, Zhe‐Sheng Chen, Kun Hee Lee, Martin G. Belinsky	129
15	Transport of Cyclic Nucleotides and Estradiol 17-β-d-Glucuronide by Multidrug Resistance Protein 4 2001 ·Journal of Biological Chemistry ·Zhe‐Sheng Chen, Kun Hee Lee, Gary D. Kruh	325
16	Basic Science of Cancer 2000 ·Gary D. Kruh, Kenneth D. Tew	2
17	Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents. 1999 ·PubMed ·Hao Zeng, Lisa J. Bain, Martin G. Belinsky, Gary D. Kruh	137
18	Amplification of the ATP-binding cassette 2 transporter gene is functionally linked with enhanced efflux of estramustine in ovarian carcinoma cells. 1998 ·PubMed ·Naomi Laing, Martin G. Belinsky, Gary D. Kruh, Daphne W. Bell, Jonathan T. Boyd, Linda R. Barone, Joseph R. Testa, Kenneth D. Tew	65
19	Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain. 1996 ·PubMed ·Tami H. Mysliwiec, R Perego, Gary D. Kruh	16
20	Expression Pattern of MRP in Human Tissues and Adult Solid Tumor Cell Lines 1995 ·JNCI Journal of the National Cancer Institute ·Gary D. Kruh, (unknown), Andrew K. Godwin, Andrew M. Chan	78

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact